drugset / Trial / NCT04686539
Synthetic CBD as a Therapy for COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.
Timeline
- Start
- 2021-01-20
- Primary completion
- 2021-11
- Completion
- 2022-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBD | Unknown | — | Other |